Cardio Flow
Manufacturing · Minnesota, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
525 Main St, Saint Paul, Minnesota, 5511...Phone Number
(651) 253-1754Website
www.cardioflow.netRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Cardio Flow
Cardio Flow, Inc. specializes in the development of the FreedomFlow Orbital Atherectomy Platform, designed to provide physicians with an efficient and flexible solution for treating complex Peripheral Artery Disease (PAD). The platform features a unique mechanism of action that allows for treatment across a range of vessel diameters, optimizing workflow and minimizing costs for hospitals and clinics. With its innovative design, the FreedomFlow platform enhances the ability to treat multiple blockages and lesions effectively. Cardio Flow aims to support healthcare providers in reducing PAD-related amputations through advanced medical technology.Explore more
Cardio Flow Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cardio Flow your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Cardio Flow
Click to see if Cardio Flow had a recent Job posting/layoffs
Product Launch: Get notified when Cardio Flow launches new products
Funding: Get notified immidiatlly once Cardio Flow has new funding data
Check out if Cardio Flow is spiking on competitors!
Website visits: Recent activity has been detected on your website
Check if Cardio Flow has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Cardio Flow recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Cardio Flow, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Cardio Flow as Masked Content
Find 3 more new buyers
Compare Similar Companies to Cardio Flow
Compare insights from companies similar to Cardio Flow, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Cardio Flow is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Cardio Flow is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Cardio Flow.
Cardio Flow financials insights
Gather financial insights about Cardio Flow, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Unspecified
$4.3M
Cardio Flow Tech Stack
A closer look at the technologies used by Cardio Flow
See more technologies
Cardio Flow News & Media
Cardio Flow, Inc., Announces U.S. Food and Drug Administration (FDA) 510(k) Clearance for its FreedomFlow® Orbital Atherectomy Peripheral Platform
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardio Flow, Inc., a privately held medical device company and developer of minimally invasive devices to treat peripheral artery disease (PAD), today announced it recently received U.S. Food and Drug Administration (FDA) 510(k) clearance for the company’s FreedomFlow Orbital Atherectomy Peripheral Platform. The FreedomFlow platform is designed with a modern mechanism of action to clear plaque blockages in the arteries of the legs. This proprietary, catheter-baCardio Flow, Inc., Announces FDA Clearance for FreedomFlow® Peripheral Guidewire, plus First Commercial Case Completed in U.S.
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardio Flow, Inc., a medical device company and developer of minimally invasive peripheral vascular devices to treat peripheral artery disease (PAD), today announced it recently received U.S. Food and Drug Administration (FDA) clearance for the company’s FreedomFlow® Peripheral Guidewire. The FreedomFlow guidewire is stainless steel core-to-tip design with a fixed distal-spring coil which was developed to provide exceptional support for diagnostic and therapeutCardio Flow secures funding for device that removes plaque from arteries.
Early-stage medical device company, Cardio Flow, Inc. based out of St. Paul, Minnesota received $4.3 million in equity funding from an undisclosed angel investor in early June. This funding coincides with the company’s engagement in their First-in-Human (FIH) clinical trial. Founded in 2014, Cardio Flow, Inc. is run by CEO, Michael J. Kallok, Ph.D., a… The post Cardio Flow secures funding for device that removes plaque from arteries. appeared first on Silicon Prairie News.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cardio Flow
Sign Up For FreeTo access detailed company insights
Cardio Flow, Inc. specializes in the development of the FreedomFlow Orbital Atherectomy Platform, designed to provide physicians with an efficient and flexible solution for treating complex Peripheral Artery Disease (PAD). The platform features a unique mechanism of action that allows for treatment across a range of vessel diameters, optimizing wor... Read More
